Evidence map›Paper›PMID 32788350›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

MicroRNA-dependent inhibition of PFN2 orchestrates ERK activation and pluripotent state transitions by regulating endocytosis.

Carolyn Sangokoya, Robert Blelloch

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. G1-phase progression in pluripotent stem cells.Cellular and molecular life sciences : CMLS · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Carolyn SangokoyaThe Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Center for Reproductive Sciences, University of California, San Francisco, CA 94143.ORCID 0000-0002-9731-3446
Robert BlellochThe Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Center for Reproductive Sciences, University of California, San Francisco, CA 94143; Robert.Blelloch@ucsf.edu.ORCID 0000-0002-1975-0798
University of California, San Francisco · US

Funding

Rewiring of the pluripotency enhancer network during early mammalian developmentR01GM122439 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLELLOCH, ROBERT · 2017 to 2020
$1.7M
Iteratively redefining developmental potential through poised enhancersR01GM125089 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLELLOCH, ROBERT · 2017 to 2020
$1.5M
Mapping post-transcriptional RNA binding regulatory networks within embryonic stem cell fate transitionF32HD088051 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SANGOKOYA, CAROLYN O · 2016 to 2018
$190k
NICHD NIH HHS F32 HD088051NIGMS NIH HHS R01 GM122439NIGMS NIH HHS R01 GM125089
6 · The paper itself

Abstract

Profilin2 (PFN2) is a target of the embryonic stem cell (ESC)-enriched miR-290 family of microRNAs (miRNAs) and an actin/dynamin-binding protein implicated in endocytosis. Here we show that the miR-290-PFN2 pathway regulates many aspects of ESC biology. In the absence of miRNAs, PFN2 is up-regulated in ESCs, with a resulting decrease in endocytosis. Reintroduction of miR-290, knockout of

Indexed as

MAP Kinase Signaling System3' Untranslated RegionsAnimalsCell DifferentiationCell LineEmbryonic Stem CellsEndocytosisHumansMiceMice, KnockoutMicroRNAsPluripotent Stem CellsProfilinsSignal Transduction3' Untranslated RegionsMicroRNAsMIRN290 microRNA, mousePFN2 protein, humanPfn2 protein, mouseProfilinsembryonic stem cellsendocytosisFGF/ERK signalingmicroRNAsPFN2

Identifiers

PMID32788350
PMCPMC7456128
OpenAlexW3048759565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.